• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全科医疗环境中跨性别和性别多样化患者的激素治疗。

Hormone therapy for trans and gender diverse patients in the general practice setting.

机构信息

BM (UK), FRACGP, Medical Educator, Northern Territory General Practice Education (NTGPE), Charles Darwin University, NT; General Practitioner, Pandanus Medical NT, NT.

出版信息

Aust J Gen Pract. 2020 Jul;49(7):385-390. doi: 10.31128/AJGP-01-20-5197.

DOI:10.31128/AJGP-01-20-5197
PMID:32599993
Abstract

BACKGROUND

In recent years there has been a significant increase in the number of trans, gender diverse and non-binary (TGDNB) people accessing healthcare. For many of these individuals the first port of call will be to their local general practitioner (GP). The TGDNB community is a high-priority population with the highest suicide rates of any population group in Australia. There is evidence that mental health outcomes improve significantly when individuals are able to access gender-affirming hormones.

OBJECTIVE

The aim of this article is to provide GPs working in Australia with a practical guide to prescribe gender-affirming hormone therapy to TGDNB patients.

DISCUSSION

GPs are ideally placed to provide care for TGDNB patients in the primary care setting. Gender incongruence is no longer viewed as a mental health disorder. In recent years there has been a move away from mandatory psychiatric assessment to more contemporary patient-centred models of care.

摘要

背景

近年来,越来越多的跨性别、性别多样化和非二进制(TGDNB)人士开始寻求医疗保健。对于这些人来说,他们的第一站通常是当地的全科医生(GP)。TGDNB 群体是一个高优先级的群体,其自杀率是澳大利亚所有群体中最高的。有证据表明,当个人能够获得性别肯定激素时,心理健康状况会显著改善。

目的

本文的目的是为在澳大利亚工作的全科医生提供一份实用指南,指导他们为 TGDNB 患者开具性别肯定激素治疗的处方。

讨论

全科医生是在初级保健环境中为 TGDNB 患者提供护理的理想人选。性别不一致不再被视为一种精神健康障碍。近年来,人们已经从强制性的精神科评估转向更现代的以患者为中心的护理模式。

相似文献

1
Hormone therapy for trans and gender diverse patients in the general practice setting.全科医疗环境中跨性别和性别多样化患者的激素治疗。
Aust J Gen Pract. 2020 Jul;49(7):385-390. doi: 10.31128/AJGP-01-20-5197.
2
Supporting the health of trans patients in the context of Australian general practice.在澳大利亚全科医疗环境下支持跨性别患者的健康。
Aust J Gen Pract. 2020 Jul;49(7):401-405. doi: 10.31128/AJGP-02-20-5226.
3
Experiences of Australian transgender, gender-diverse and non-binary patients accessing and receiving gender-affirming care.澳大利亚跨性别者、性别多元者及非二元性别患者获得性别肯定治疗的经历。
Aust J Gen Pract. 2025 Mar;54(3):143-151. doi: 10.31128/AJGP-06-24-7324.
4
Position statement on the hormonal management of adult transgender and gender diverse individuals.关于成年跨性别和性别多样化个体的激素管理的立场声明。
Med J Aust. 2019 Aug;211(3):127-133. doi: 10.5694/mja2.50259. Epub 2019 Jul 4.
5
HIV seropositivity and viral non-suppression in transgender, non-binary, and gender-diverse people in primary care receiving gender-affirming hormone therapy in the USA between 2013 and 2019 (LEGACY): an observational, longitudinal, cohort study.2013年至2019年美国接受性别确认激素治疗的初级保健中跨性别、非二元性别和性别多样化人群的HIV血清阳性和病毒未抑制情况(LEGACY):一项观察性纵向队列研究
Lancet HIV. 2025 Apr;12(4):e283-e292. doi: 10.1016/S2352-3018(25)00004-9. Epub 2025 Mar 27.
6
Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia.澳大利亚跨性别和性别多样化成年人的性别肯定激素治疗。
Intern Med J. 2024 Sep;54(9):1450-1457. doi: 10.1111/imj.16413. Epub 2024 Jul 26.
7
Reduction in Mental Health Treatment Utilization Among Transgender Individuals After Gender-Affirming Surgeries: A Total Population Study.跨性别个体接受性别肯定手术后心理健康治疗利用率降低:一项全人群研究。
Am J Psychiatry. 2020 Aug 1;177(8):727-734. doi: 10.1176/appi.ajp.2019.19010080. Epub 2019 Oct 4.
8
Non-Binary and Binary Gender Identity in Australian Trans and Gender Diverse Individuals.澳大利亚跨性别和性别多样化个体中的非二元性别认同和二元性别认同。
Arch Sex Behav. 2020 Oct;49(7):2673-2681. doi: 10.1007/s10508-020-01689-9. Epub 2020 Apr 13.
9
SIGIS-SIAMS-SIE position statement of gender affirming hormonal treatment in transgender and non-binary people.SIGIS-SIAMS-SIE 关于跨性别和非二元性别者性别肯定激素治疗的立场声明。
J Endocrinol Invest. 2022 Mar;45(3):657-673. doi: 10.1007/s40618-021-01694-2. Epub 2021 Oct 22.
10
Transgender and gender diverse people with endometriosis: A perspective on affirming gynaecological care.患有子宫内膜异位症的跨性别和性别多样化人群:肯定妇科护理的视角。
Womens Health (Lond). 2024 Jan-Dec;20:17455057241251974. doi: 10.1177/17455057241251974.

引用本文的文献

1
Histological ovarian features and hormonal determinations in assigned females at birth transgender individuals according to different testosterone preparations.根据不同的睾酮制剂,对出生时被指定为女性的跨性别者进行组织学卵巢特征和激素测定。
Front Endocrinol (Lausanne). 2024 Oct 28;15:1458846. doi: 10.3389/fendo.2024.1458846. eCollection 2024.
2
Transgender and gender diverse people with endometriosis: A perspective on affirming gynaecological care.患有子宫内膜异位症的跨性别和性别多样化人群:肯定妇科护理的视角。
Womens Health (Lond). 2024 Jan-Dec;20:17455057241251974. doi: 10.1177/17455057241251974.
3
Impact of Distinct Antiandrogen Exposures on the Plasma Metabolome in Feminizing Gender-affirming Hormone Therapy.
不同雄激素拮抗剂暴露对女性性别肯定激素治疗中血浆代谢组的影响。
J Clin Endocrinol Metab. 2024 Oct 15;109(11):2857-2871. doi: 10.1210/clinem/dgae226.
4
Gender-Affirming Hormone Therapy for the Trans, Gender Diverse, and Nonbinary Community: Coordinating World Professional Association for Transgender Health and Informed Consent Models of Care.为跨性别、性别多元和非二元性别人群提供性别肯定激素治疗:世界跨性别健康专业协会与知情同意护理模式的协调
Transgend Health. 2023 Mar 31;8(2):137-148. doi: 10.1089/trgh.2021.0069. eCollection 2023 Apr.
5
Liver function in transgender persons: Challenges in the COVID-19 era.跨性别者的肝功能:新冠疫情时代的挑战
World J Clin Cases. 2023 Jan 16;11(2):299-307. doi: 10.12998/wjcc.v11.i2.299.
6
Potential immunological effects of gender-affirming hormone therapy in transgender people - an unexplored area of research.性别肯定激素疗法对跨性别者潜在的免疫影响——一个尚未探索的研究领域。
Ther Adv Endocrinol Metab. 2022 Dec 10;13:20420188221139612. doi: 10.1177/20420188221139612. eCollection 2022.
7
Effects of low-dose oral micronised progesterone on sleep, psychological distress, and breast development in transgender individuals undergoing feminising hormone therapy: a prospective controlled study.低剂量口服微粒化孕酮对接受女性化激素治疗的跨性别者睡眠、心理困扰及乳房发育的影响:一项前瞻性对照研究
Endocr Connect. 2022 May 23;11(5):e220170. doi: 10.1530/EC-22-0170.
8
Immune Sexual Dimorphism: Connecting the Dots.免疫性别二态性:关联解析。
Physiology (Bethesda). 2022 Mar 1;37(2):55-68. doi: 10.1152/physiol.00006.2021. Epub 2021 Sep 13.
9
Sexual Dimorphism in Innate Immunity: The Role of Sex Hormones and Epigenetics.固有免疫中的性别二态性:性激素与表观遗传学的作用
Front Immunol. 2021 Jan 21;11:604000. doi: 10.3389/fimmu.2020.604000. eCollection 2020.
10
Unforeseen uses of oral contraceptive pills: Exploratory study in Jordanian community pharmacies.口服避孕药的意外用途:约旦社区药房的探索性研究。
PLoS One. 2020 Dec 21;15(12):e0244373. doi: 10.1371/journal.pone.0244373. eCollection 2020.